PR Newswire Online News – I wish I had more to offer

LNTH Investors Have Opportunity to Lead Lantheus Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm

LOS ANGELES, Nov. 3, 2025 /PRNewswire/ — The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Lantheus Holdings, Inc. (“Lantheus” or “the Company”) (NASDAQ: LNTH) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange… Continue reading LNTH Investors Have Opportunity to Lead Lantheus Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm

FLYE Investors Have Opportunity to Lead Fly-E Group, Inc. Securities Fraud Lawsuit with the Schall Law Firm

LOS ANGELES, Nov. 3, 2025 /PRNewswire/ — The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Fly-E Group, Inc. (“Fly-E” or “the Company”) (NASDAQ: FLYE) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and… Continue reading FLYE Investors Have Opportunity to Lead Fly-E Group, Inc. Securities Fraud Lawsuit with the Schall Law Firm

Tronox Holdings plc Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights – TROX

LOS ANGELES, Nov. 3, 2025 /PRNewswire/ — The DJS Law Group reminds investors of a class action lawsuit against Tronox Holdings plc (“Tronox” or “the Company”) (NYSE: TROX ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders… Continue reading Tronox Holdings plc Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights – TROX

Changsha: A City Brimming with Youthful Vitality

BEIJING, Nov. 3, 2025/PRNewswire/ — A news report from China Daily: From steaming morning bowls to sizzling midnight markets, the pulse of #Changsha never stops. This is a city where a millennium of craftsmanship inspires smart manufacturing, and where dreams are launched under fireworks over the Xiang River. Truly, a bridge from a rich past… Continue reading Changsha: A City Brimming with Youthful Vitality

SIGRID Expands into the U.S. Physician Channel Following Successful Pilot Program

STOCKHOLM, Nov. 3, 2025 /PRNewswire/ — SIGRID, the Swedish innovative consumer care company behind the groundbreaking Glucose Stabiliser powered by patented SiPore® technology, today announced its expansion into the U.S. physician channel following a successful pilot program with selected integrative and functional medicine clinics. Continue Reading SIGRID Glucose Stabiliser As part of this initiative, SIGRID has partnered with an experienced industry… Continue reading SIGRID Expands into the U.S. Physician Channel Following Successful Pilot Program

bp unlocks value, divests non-controlling interests in US onshore midstream assets for $1.5 billion

bp divests non-controlling interests in Permian and Eagle Ford midstream assets to private investor Sixth Street for $1.5 billion Agreement enables bp to unlock capital from infrastructure, while retaining operatorship and control of strategic midstream assets Transaction delivers a material contribution towards bp’s 2025 expected divestment proceeds and target of $20 billion of divestments by the end… Continue reading bp unlocks value, divests non-controlling interests in US onshore midstream assets for $1.5 billion

ArisGlobal Announces NavaX™ Agents Suite

Orchestrated by the NavaX Super Agent, the Suite includes previously launched MedDRA Coding Agent and upcoming cross-domain Agents BOSTON, Nov. 3, 2025 /PRNewswire/ — ArisGlobal, an AI-first technology company at the forefront of life sciences and creator of LifeSphere®, today announced the launch of NavaX™ Agents, a major advancement in the company’s AI strategy that brings… Continue reading ArisGlobal Announces NavaX™ Agents Suite

Sandstone Easydrip™ Plus with Hextra Tech™ Hexagonal Broad Hub Delivers Steadier, More Comfortable Insulin Injections

SHANGHAI, Nov. 3, 2025 /PRNewswire/ — A peer-reviewed article by researchers at the University of Shanghai for Science and Technology (USST), published in an international biomedical engineering journal, reports that the Hextra Tech™ hexagonal, broad-platform hub used in Sandstone Easydrip™ Plus pen needles improves injection stability and user comfort versus conventional narrow hubs in laboratory bench… Continue reading Sandstone Easydrip™ Plus with Hextra Tech™ Hexagonal Broad Hub Delivers Steadier, More Comfortable Insulin Injections

Arctic Therapeutics Receives EMA Approval for Phase IIa Study of AT-001 in Alzheimer’s Disease

The European Medicines Agency (EMA) authorises initiation of a Phase IIa study evaluating AT-001 in patients diagnosed with Alzheimer’s disease EMA grants Orphan Drug Designation (ODD) to AT-001 for hereditary cystatin C amyloid angiopathy (HCCAA), a rare familial dementia REYKJAVÍK, Iceland, Nov. 3, 2025 /PRNewswire/ — Arctic Therapeutics (ATx), an Iceland-based clinical-stage biopharmaceutical company, today announced… Continue reading Arctic Therapeutics Receives EMA Approval for Phase IIa Study of AT-001 in Alzheimer’s Disease